Serum miR-342-3p Acts as a Biomarker for Systemic Lupus Erythematosus and Participates in the Disease Progression

References

• Hanly JG, Su L, Urowitz MB, et al. A longitudinal analysis of outcomes of lupus nephritis in an international inception cohort using a multistate model approach. Arthritis Rheumatol. 2016;68(8):1932–1944. doi:10.1002/art.39674
   PubMed Web of Science ®Google Scholar
• Durcan L, O’Dwyer T, Petri M. Management strategies and future directions for systemic lupus erythematosus in adults. Lancet. 2019;393(10188):2332–2343. doi:10.1016/S0140-6736(19)30237-5
   PubMed Web of Science ®Google Scholar
• Liu S, Cheng Y, Xie Z, et al. A conscious resting state fMRI study in SLE patients without major neuropsychiatric manifestations. Front Psychiatry. 2018;9:677. doi:10.3389/fpsyt.2018.00677
   Web of Science ®Google Scholar
• Flynn A, Gilhooley E, O’Shea F, Wynne B. The use of SLICC and ACR criteria to correctly label patients with cutaneous lupus and systemic lupus erythematosus. Clin Rheumatol. 2018;37(3):817–818. doi:10.1007/s10067-018-3999-0
   Web of Science ®Google Scholar
• Satish S, Deka P, Shetty MS. A clinico-pathological study of lupus nephritis based on the international society of nephrology-renal pathology society 2003 classification system. J Lab Physicians. 2017;9(3):149–155. doi:10.4103/JLP.JLP_44_16
   Google Scholar
• Sebastiani GD, Prevete I, Iuliano A, Minisola G. The importance of an early diagnosis in systemic lupus erythematosus. Isr Med Assoc J. 2016;18(3–4):212–215.
   Web of Science ®Google Scholar
• Shumnalieva R, Kachakova D, Shoumnalieva-Ivanova V, Miteva P, Kaneva R, Monov S. Whole peripheral blood miR-146a and miR-155 expression levels in Systemic lupus erythematosus patients. Acta Reumatol Port. 2018;43(3):217–225.
   PubMed Web of Science ®Google Scholar
• Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 2005;120(1):15–20. doi:10.1016/j.cell.2004.12.035
   PubMed Web of Science ®Google Scholar
• O’Connell RM, Rao DS, Chaudhuri AA, Baltimore D. Physiological and pathological roles for microRNAs in the immune system. Nat Rev Immunol. 2010;10(2):111–122. doi:10.1038/nri2708
   PubMed Web of Science ®Google Scholar
• Tang Y, Luo X, Cui H, et al. MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. Arthritis Rheum. 2009;60(4):1065–1075. doi:10.1002/art.24436
   PubMed Web of Science ®Google Scholar
• Ding S, Liang Y, Zhao M, et al. Decreased microRNA-142-3p/5p expression causes CD4+ T cell activation and B cell hyperstimulation in systemic lupus erythematosus. Arthritis Rheum. 2012;64(9):2953–2963. doi:10.1002/art.34505
   Google Scholar
• Stagakis E, Bertsias G, Verginis P, et al. Identification of novel microRNA signatures linked to human lupus disease activity and pathogenesis: miR-21 regulates aberrant T cell responses through regulation of PDCD4 expression. Ann Rheum Dis. 2011;70(8):1496–1506. doi:10.1136/ard.2010.139857
   PubMed Web of Science ®Google Scholar
• Carlsen AL, Schetter AJ, Nielsen CT, et al. Circulating microRNA expression profiles associated with systemic lupus erythematosus. Arthritis Rheum. 2013;65(5):1324–1334. doi:10.1002/art.37890
   PubMedGoogle Scholar
• Aringer M, Costenbader K, Daikh D, et al. 2019 European league against rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis. 2019;78(9):1151–1159. doi:10.1136/annrheumdis-2018-214819
   PubMed Web of Science ®Google Scholar
• Yuan Y, Zhao L, Ye Z, Ma H, Wang X, Jiang Z. Association of toll-like receptor 9 expression with prognosis of systemic lupus erythematosus. Exp Ther Med. 2019;17(4):3247–3254. doi:10.3892/etm.2019.7290
   Web of Science ®Google Scholar
• Pamuk ON, Akbay FG, Donmez S, Yilmaz N, Calayir GB, Yavuz S. The clinical manifestations and survival of systemic lupus erythematosus patients in Turkey: report from two centers. Lupus. 2013;22(13):1416–1424. doi:10.1177/0961203313499956
   Web of Science ®Google Scholar
• Maselli A, Conti F, Alessandri C, et al. Low expression of estrogen receptor beta in T lymphocytes and high serum levels of anti-estrogen receptor alpha antibodies impact disease activity in female patients with systemic lupus erythematosus. Biol Sex Differ. 2016;7:3. doi:10.1186/s13293-016-0057-y
   Web of Science ®Google Scholar
• Ceccarelli F, Perricone C, Cipriano E, et al. Joint involvement in systemic lupus erythematosus: from pathogenesis to clinical assessment. Semin Arthritis Rheum. 2017;47(1):53–64. doi:10.1016/j.semarthrit.2017.03.022
   PubMed Web of Science ®Google Scholar
• Honarpisheh M, Kohler P, von Rauchhaupt E, Lech M. The involvement of MicroRNAs in modulation of innate and adaptive immunity in systemic lupus erythematosus and lupus nephritis. J Immunol Res. 2018;2018:4126106. doi:10.1155/2018/4126106
   PubMed Web of Science ®Google Scholar
• Qu B, Shen N. miRNAs in the pathogenesis of systemic lupus erythematosus. Int J Mol Sci. 2015;16(5):9557–9572. doi:10.3390/ijms16059557
   PubMed Web of Science ®Google Scholar
• Wang W, Zhang Y, Zhu B, et al. Plasma microRNA expression profiles in Chinese patients with rheumatoid arthritis. Oncotarget. 2015;6(40):42557–42568. doi:10.18632/oncotarget.6449
   PubMedGoogle Scholar
• Te JL, Dozmorov IM, Guthridge JM, et al. Identification of unique microRNA signature associated with lupus nephritis. PLoS One. 2010;5(5):e10344. doi:10.1371/journal.pone.0010344
   PubMed Web of Science ®Google Scholar
• Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum. 1992;35(6):630–640. doi:10.1002/art.1780350606
   PubMed Web of Science ®Google Scholar
• Gladman DD, Ibanez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol. 2002;29(2):288–291.
   PubMed Web of Science ®Google Scholar
• Hawker G, Gabriel S, Bombardier C, Goldsmith C, Caron D, Gladman D. A reliability study of SLEDAI: a disease activity index for systemic lupus erythematosus. J Rheumatol. 1993;20(4):657–660.
   PubMed Web of Science ®Google Scholar